Browse All

Current Filters

CLEAR FILTER x

TITLE

Weight Loss With Atogepant in Participants with Migraine and Overweight or Obesity: Interim Analysis of a Phase 3, Multicenter, Open-label, 156-week Extension Study

Safety and Tolerability of Anti-PACAP Monoclonal Antibody Lu AG09222 when Co-administered with a Gepant in Participants with Migraine

Qualitative Study to Characterize the Patient-reported Experience of Menstrual Migraine

Characterizing a Population Reporting Menstrually Related Migraine: Multi-country Results from the Chronic Migraine Epidemiology and Outcomes–international (CaMEO-I) Study

Hybrid Concept Elicitation and Cognitive Debriefing of Patient-reported Outcome Measures in Patients with Menstrual Migraine